Fredun Pharmaceuticals Ltd — Important, 09-04-2026: Company Update

The company's Board has allotted 40,000 new equity shares, each with a face value of Rs. 10, to a promoter. This issuance follows the conversion of previously issued warrants after the promoter remitted the balance consideration of Rs. 3.75 crore. The shares were issued at Rs. 1250 per share, which includes a premium of Rs. 1240. This move increases the company's equity capital and indicates a promoter's continued commitment, bringing in fresh funds.